秋元 哲夫
| 1) 氏名 | 秋元 哲夫（あきもと てつお） |
| 2) 所属・職務 | 粒子線医学開発部 部長 (放射線治療科長併任) 東京女子医科大学 客員教授 |
| 3) 電話番号 | 04-7134-6918 |
| 4) FAX番号 | 04-7134-6918 |
| 5) Eメール | takimoto @ east.ncc.go.jp |
| 6) 専門領域 | 放射線治療、粒子線治療 |
| 7) 所属学会 | American Society for Therapeutic Radiology and Oncology、American Society of Clinical Oncology、American Association for Cancer Research、日本癌学会、日本癌治療学会、日本医学放射線学会、日本放射線腫瘍学会、日本頭頚部癌学会、日本食道学会、日本乳癌学会、日本がん分子標的治療学会、など |
| 8) キーワード | 放射線治療、陽子線治療、臨床試験、化学放射線療法、放射線生物 |
| 9) 共同研究が可能なテーマ | |
| ・ 放射線治療・粒子線治療の臨床試験 ・ 化学放射線療法 ・ 強度変調放射線治療 |
|
| 10) 現在の主な研究テーマ及びその概要 | |
| ・ 陽子線治療に関する技術開発 ・ 陽子線治療を用いた臨床試験 ・ 高精度放射線治療 |
|
| 11) 主な論文 | |
| (1) Akimoto T, Mitsuhashi N: Radiation Oncology and Molecular-Targeted
Therapy for EGFR and its Signal Transduction Pathways: Molecular Basis
and Clinical Application for Improvement of Radiotherapeutic Outcomes.
Curr Signal Transduct Ther 5(3): 197-205, 2010. (2) Nakamura K, Tahara M, Kiyota N, Hayashi R, Akimoto T, Fukuda H, Fujii M, Boku N. Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706). Jpn J Clin Oncol. 39(7):460-3, 2009. (3) Muramatsu H, Akimoto T, Midori Kita, Katsuya Maebayashi, Norio Mitsuhashi. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy. Anticancer Res 28(6B): 3859-3864, 2008. (4) Nakamura K, Mizowaki T, Imada H, Karasawa K, Uno T, Onishi H, Nihei K, Sasaki S, Ogura M, Akimoto T. External-beam radiotherapy for localized or locally advanced prostate cancer in Japan: a multi-institutional outcome analysis. Jpn J Clin Oncol. 38(3): 200-4, 2008. (5) Isomura M, Oya N, Tachiiri S, Kaneyasu Y, Nishimura Y, Akimoto T, Hareyama M, Sugita T, Mitsuhashi N, Yamashita T, Aoki M, Sai H, Hirokawa Y, Sakata K, Karasawa K, Tomida A, Tsuruo T, Miki Y, Noda T, Hiraoka M. IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res. 14(20): 6683-9, 2008. (6) Yamamoto T, Ito K, Miyakubo M, Takechi H, Suzuki K, Akimoto T, Ishikawa H, Nakano T. (7) Nomogram Ranking as New Objective Evaluation Method in Various Treatment Strategies for Patients with Prostate Cancer with Various Clinicopathologic Backgrounds. Urology 2(4): 892-7, 2008. (8) Ebara T, Akimoto T, Kato H, Noda S, Tamaki T, Harada K, Shirai K, Kawamura H, Sakurai H, Nakano T. Late rectal bleeding and genitourinary morbidity after high dose rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer. Jpn J Ther Radiol Oncol 19: 93-97, 2007. (9) Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K Furuya N, Hayakawa K, Mitsuhashi N, Nakano T. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys. 15; 64(4): 995-1001, 2006. (10) Akimoto T, Katoh H, Kitamoto Y, Tamaki T, Harada K, Shirai K, Nakano T. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding. Int J Radiat Oncol Biol Phys. 2006 Jun 1; 65(2): 364-70 (11) Akimoto T, Katoh H, Kitamoto Y, Shirai K, Shioya M, Nakano T. Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: Comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization. Int J Radiat Oncol Biol Phys. 1; 64(5): 1360-6, 2006. |
|
陽子線治療についてはこちら